CAREFUSION CORP Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 74 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-03-17: Reporting owner OHALLERAN MICHAEL D; Form 4; Security Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2015-03-17: Reporting owner MILLER EDWARD D JR; Form 4; Security Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2015-03-17: Reporting owner LUCIER GREGORY T; Form 4; Security Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2015-03-17: Reporting owner LOSH J MICHAEL; Form 4; Security Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-03-17 | OHALLERAN MICHAEL D Director | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,874 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | MILLER EDWARD D JR Director | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,874 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | LUCIER GREGORY T Director | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,874 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | LOSH J MICHAEL Director | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | +2,874 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | KOSECOFF JACQUELINE B Director | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,874 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | FRIEL ROBERT F Director | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,874 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | FRANCIS PHILIP L Director | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,874 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Bose Supratim Director | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,874 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,234 3,234 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,563 2,563 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,234 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,563 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,120 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,078 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,437 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,210 20,210 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,132 17,132 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,950 12,950 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,210 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,132 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,950 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,369 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,711 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,257 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Paolucci Michael E Officer (EVP, Human Resources) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,681 12,681 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Paolucci Michael E Officer (EVP, Human Resources) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,681 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Paolucci Michael E Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,097 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Paolucci Michael E Officer (EVP, Human Resources) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,107 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,094 27,094 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,374 22,374 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,213 18,213 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,094 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −22,374 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −18,213 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,516 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,458 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,207 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,438 13,438 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,952 9,952 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,523 7,523 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −13,438 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,952 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,523 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,240 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,188 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | La Fortune Gordon Officer (EVP, EMEA/ANZ Commercial Ops) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,217 0 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,888 45,888 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,006 35,006 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,462 26,462 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,888 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,006 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −26,462 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,648 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,669 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,830 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +139,978 139,978 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +107,824 107,824 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +79,131 79,131 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −139,978 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −107,824 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −79,131 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,330 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,942 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −44,348 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,048 11,048 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,956 8,956 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Performance Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,770 6,770 owned after | no price filed | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,048 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,956 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,770 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,842 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,986 0 owned after | $0.00 | 2015-03-19 | |
| 2015-03-17 | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 4 | Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,794 0 owned after | $0.00 | 2015-03-19 | |
| 2015-02-15 | Wygant Jonathan Officer (SVP, Chief Accounting Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,732 0 owned after | no price filed | 2015-02-18 |